Acquired by the Canadian firm Satisfy Health, the CA firm Docbot, Inc. is a medical informatics company developing artificial intelligence-driven applications for clinical decision support, aggregated patient information, and population health analytics for physicians and specialists. An area of emphasis also reported is healthcare software developed by the firm using an artificial intelligence-enabled platform to identify colon polyps in real time. VC raised by the firm in 2019 used to support several clinical trials, mainly focused on polyp detection - one particularly focused on Barrettâs Esophagus, a serious complication of gastroesophageal reflux disease. The firm's software integrates IT systems to make billing and documentation more efficient, tracks withdrawal time and intubation rate â which is an important indicator of colonoscopy quality â and examines bowel prep and adenoma detection rate. Principals of the firm report multiple real-time AI-based algorithms with high accuracy that can facilitate doctors to achieve high performance relevant to colon cancer prevention, early detection of esophageal cancer, and reduced âtime-to-findâ abnormalities of the intestine with indication also that the team has already incorporated the detection technology into approximately 6,000 pr
